TRAW

CAUTREELS WERNER

Known title: Chief Executive OfficerCIK: 0001237419

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 2, 2026

Traws Pharma listed in Benzinga health care movers. Traws Pharma was included in Benzinga's recent lists of health care stocks moving in pre-market and after-market sessions. These mentions indicate that the stock experienced price volatility relative to its peers during those trading periods. The company's shares currently trade near the middle of their 52-week range, with an average analyst target of $1.00.

this person other insiders at TRAW

Transaction History

TRAW▲ Buy$0
TRAW▲ Buy$963
TRAW▲ Buy—

We use analytics to understand how market-wall is used. No personal data is sold.